Hematology is an international journal dedicated to advancing the understanding and treatment of blood disorders and related malignancies. Focusing on cutting-edge research, it covers a broad spectrum of topics, ranging from basic science discoveries to clinical advances in hematology and oncology. The journal serves as a vital platform for disseminating knowledge to researchers, clinicians, and healthcare professionals worldwide.
Key areas of interest include hematopoiesis, hemostasis, thrombosis, and disorders of red and white blood cells. The journal also publishes articles on leukemia, lymphoma, myeloma, and other blood cancers, exploring new diagnostic tools, treatment modalities, and strategies for improving patient outcomes. It is indexed in major scientific databases such as Scopus and Web of Science, increasing its impact in the scientific community.
Hematology plays a crucial role in promoting collaboration and innovation in the field. By providing a forum for the exchange of ideas and research findings, the journal contributes to the development of more effective therapies and improved quality of life for patients with hematological disorders. Authors are encouraged to submit original research, reviews, and case studies that advance our understanding of blood diseases and malignancies.